ArticleFrontiers in pharmacology2020

BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma.

Hongyun Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.